abstract |
The present invention relates to novel compounds. The compounds of the present invention are tyrosine kinase inhibitors. In particular, the compounds of the present invention are useful as inhibitors of bruton tyrosine kinase (BTK). The present invention also contemplates the use of compounds which are treatable by inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia, and immunological diseases. |